Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Roivant Sciences Ltd. (ROIV) had Return on Equity of -14.07% for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$29.05M |
|
$-171.98M |
|
$0.91M |
|
$28.14M |
|
$1.03B |
|
$-1.00B |
|
$321.70M |
|
$-681.59M |
|
$-736.78M |
|
$-729.76M |
|
$-729.76M |
|
$-356.73M |
|
$-781.05M |
|
$-1.00B |
|
$-989.22M |
|
725.40M |
|
725.40M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$5.44B |
|
-- |
|
-- |
|
-- |
|
$249.74M |
|
$5.19B |
|
$5.19B |
|
$5.19B |
|
695.94M |
|
| Cash Flow Statement Financials | |
$-839.45M |
|
$-1.77B |
|
$-1.22B |
|
$6.55B |
|
$2.73B |
|
$-3.82B |
|
$289.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.86% |
|
-3453.32% |
|
-3453.32% |
|
-3404.89% |
|
-2346.02% |
|
-591.96% |
|
$-844.05M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-14.07% |
-14.07% |
|
-13.42% |
|
-14.07% |
|
$7.45 |
|
$-1.16 |
|
$-1.16 |
|